Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M BERK

Showing results (91-100 of 196) with videos related to

Pageof 20
Sort By:
Translational Psychiatry|November 29, 2012
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depressionA B Singh, C A Bousman, C H Ng, et al.
Acta Psychiatrica Scandinavica|August 21, 2012
In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopesM Maes, M Kubera, J-C Leunis, et al.
Frontiers in Neurorobotics|April 30, 2021
Generative Models for Active VisionThomas Parr, Noor Sajid, Lancelot Da Costa, et al.
Journal of Psychopharmacology (Oxford, England)|June 28, 2008
Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case seriesM F Juruena, C S Gama, M Berk, et al.
Acta Psychiatrica Scandinavica. Supplementum|April 17, 2013
Pharmacological management of unipolar depressionG S Malhi, R Hitching, M Berk, et al.
Journal of Affective Disorders|March 28, 2009
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patientsE Vieta, M Berk, W Wang, et al.
Acta Psychiatrica Scandinavica|January 19, 2020
Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analysesJ Velosa, A Delgado, E Finger, et al.
Frontiers in Artificial Intelligence|March 18, 2021
Deep Active Inference and Scene ConstructionR Conor Heins, M Berk Mirza, Thomas Parr, et al.
International Journal of Clinical Practice|March 30, 2010
Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention studyK Kelin, M Berk, M Spann, et al.
Molecular Psychiatry|October 29, 2014
Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compassJ Davis, M Maes, A Andreazza, et al.
Pageof 20

Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Translational Psychiatry|November 29, 2012
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depressionA B Singh, C A Bousman, C H Ng, et al.
Acta Psychiatrica Scandinavica|August 21, 2012
In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopesM Maes, M Kubera, J-C Leunis, et al.
Frontiers in Neurorobotics|April 30, 2021
Generative Models for Active VisionThomas Parr, Noor Sajid, Lancelot Da Costa, et al.
Journal of Psychopharmacology (Oxford, England)|June 28, 2008
Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case seriesM F Juruena, C S Gama, M Berk, et al.
Acta Psychiatrica Scandinavica. Supplementum|April 17, 2013
Pharmacological management of unipolar depressionG S Malhi, R Hitching, M Berk, et al.
Journal of Affective Disorders|March 28, 2009
Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patientsE Vieta, M Berk, W Wang, et al.
Acta Psychiatrica Scandinavica|January 19, 2020
Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analysesJ Velosa, A Delgado, E Finger, et al.
Frontiers in Artificial Intelligence|March 18, 2021
Deep Active Inference and Scene ConstructionR Conor Heins, M Berk Mirza, Thomas Parr, et al.
International Journal of Clinical Practice|March 30, 2010
Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention studyK Kelin, M Berk, M Spann, et al.
Molecular Psychiatry|October 29, 2014
Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compassJ Davis, M Maes, A Andreazza, et al.
Pageof 20